Phoenix Ambulatory Blood Pressure Monitor Project
11/20/2003 Meeting Notes

 

Attendees:
GLUMACD@polarfab.com (Daniel Glumac), edoctor@yahoo.com (Chris Fuller), haugeeng@pressenter.com (Jim Garrity), approach@minn.net (Bob Schlentz), e.nolley@ieee.org (El Nolley), jre1578@hotmail.com (Jessica Edwards), corne001@tc.umn.edu (Germaine G Cornelissen-Guillaume), Otilde & Franz Halberg.

Discussion:
Germaine: Blood pressure is typically lower at night, higher during day. Alteration in circadian rhythms can be indicative of disease. Better than mean, smaller errors, & reduce other abnormalities. Eg. Large amplitude. Treatments include relaxation, medication that reduces amplitude and mean value. Time on treatment can affect amount required, side effects, impact on circadian rhythm. Two day span measurements may differ. Mesor-hypertension & CHAT. Seven day profiles are predictive of representative of behavior that occurs over 50 percent of the time. It is of interest to identify trends - e.g. Worsening diseases. Leads to treatments that can depend on symptoms. Eg. Fast acting drug vs. slow acting drug.

Indirect measurements require time & direct measurements are instantaneous. 4/dy is minimal, 24/dy is adequate, 48/dy is better.

In future include: Jim Holte, Earl Bakken, Brian Brockway.

Chris: There are implantable devices. How expensive?

Franz: Like a pen, would be good. Current devices are way too expensive. And as easy to use as current.


 

About This Page

This page is maintained by Ellis S Nolley. It was last updated on 28 October 2004.

The author(s) provide this information as a public service, and agree to place any novel and useful inventions disclosed herein into the public domain. They are not aware that this material infringes on the patent, copyright, trademark or trade secret rights of others. However, there is a possibility that such infringement may exist without their knowledge. The user assumes all responsibility for determining if this information infringes on the intellectual property rights of others before applying it to products or services.

Copyright (C) 2004 Ellis S. Nolley. Copying and distribution of this page is permitted in any medium, provided this notice is preserved.

Back to the Meeting Archive Page

Back to the Phoenix Home Page